M&A Advisory – Healthcare and Life Sciences
Industry and market expertise underpins our award-winning advice
Our Healthcare and Life Sciences corporate finance advisory team, led by David L Jones, provides an award winning corporate finance advisory service, with a proven track record of delivering successful transactions in the marketplace.
We work closely with corporates, management teams, individuals and private equity houses on midmarket buy-side and sell-side transactions, as well as joint ventures and public sector partnerships.
The Healthcare and Life Science corporate finance advisory M&A team at Deloitte is one of the largest mid-market M&A teams operating in Europe.
The team provides a full range of financial advisory services across sub-industries, including:
- healthcare services
- consumer healthcare
- biotechnology and medical devices
- outsourced services
- healthcare IT
Our team is fully integrated with Deloitte’s wider Healthcare and Life Sciences practice, including the UK Deloitte Centre for Health Care Solutions, and the Deloitte’s Global Healthcare and Life Science practice.
We have been commended for our achievements, innovation and ground-breaking work across the healthcare sector. We have won the following awards:
Our wider advisory practice
The UK Deloitte Centre for Health Solutions generates research and insights based on the key trends, challenges and opportunities across the healthcare and life sciences industry. Please sign up to receive upcoming thought leadership publications, events and blogs from the UK Centre.
Having a global network of Healthcare and Life Science professionals allows Deloitte to operate at the forefront of the advisory community, and maintain strong relationships with financial investors on a global scale.